Trial Site Detail
Drug: |
Nilotinib or Imatinib |
|||
|---|---|---|---|---|
Trial: |
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1) |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
|||
Kootenai Cancer Center2003 Lincoln Way |
Principal Investigator: |
Brian Samuels, MD |
|---|---|
Contact: |
Robin Gustin 208 666-2295 rgustin@kmc.org |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Kootenai Cancer Center Website: |
http://www.kootenaihealth.org/index.asp?w=pages&r=26&pid=29 |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.